# Paroxetine-Clomiphene-DDGI
Modeling of published paroxetine-clomiphene-DDGI studies for model evaluation

## Repository files
Within this repository, we distribute a PK-Sim snapshot containing simulations of all published clinical studies used to evaluate the predictive performance of the paroxetine and clomiphene models regarding paroxetine-clomiphene-DDGIs, including the respective observed data digitized from literature reports. The applied models have been published previously [1,2]. 

For further details and documentation please refer to [3].


## Version information

OSP Version 11.0

## License 
The model is distributed under the [GPLv2 Lincense](https://github.com/Open-Systems-Pharmacology/Suite/blob/develop/LICENSE).

## Reference
[[1] Rüdesheim, S.; Selzer, D.; Mürdter, T.; Igel, S.; Kerb, R.; Schwab, M.; Lehr, T. Physiologically Based Pharmacokinetic Modeling to Describe the CYP2D6 Activity Score-Dependent Metabolism of Paroxetine, Atomoxetine and Risperidone. Pharmaceutics 2022, 14, 1734.](https://doi.org/10.3390/pharmaceutics14081734)

[[2] Kovar, C.; Kovar, L.; Rüdesheim, S.; Selzer, D.; Ganchev, B.; Kröner, P.; Igel, S.; Kerb, R.; Schaeffeler, E.; Mürdter, T.E.; Schwab, M.; Lehr, T. Prediction of Drug–Drug–Gene Interaction Scenarios of (E)-Clomiphene and Its Metabolites Using Physiologically Based Pharmacokinetic Modeling. Pharmaceutics 2022, 14, 2604.](https://www.mdpi.com/1999-4923/14/12/2604)

[[3] Rüdesheim S, Loer HLH, Feick D, Marok FZ, Fuhr LM, Selzer D, Teutonico, D, Schneider ARP, Solodenko J, Frechen S, vdL Maaike, Moes DJAR, Swen JJ, Schwab M, Lehr T. A Comprehensive CYP2D6 Drug-Drug-Gene Interaction Network for Application in Precision Dosing and Drug Development. Clin Pharmacol Ther. 2025, doi: 10.1002/cpt.3604.](https://pubmed.ncbi.nlm.nih.gov/39953671/)
